7Baggers
 JP Morgan Initiates Coverage on ENTA with Overweight Rating | EN  GuruFocus Sat, 15 Nov 2025 11:06:17 GMT
 Enanta rises as J.P. Morgan starts at Overweight on RSV therapy  Seeking Alpha Fri, 14 Nov 2025 16:54:35 GMT
 enanta rises as j.p. morgan starts at overweight (enta:nasdaq)  Seeking Alpha Fri, 14 Nov 2025 16:54:35 GMT
 Enanta Pharma's Earnings: A Preview  Benzinga Fri, 14 Nov 2025 14:02:33 GMT
 jp morgan initiates coverage on enta with overweight rating | en  GuruFocus Fri, 14 Nov 2025 13:06:30 GMT
 Enanta initiated with an Overweight at JPMorgan  TipRanks Fri, 14 Nov 2025 10:53:32 GMT
 JPMorgan initiates Enanta Pharmaceuticals stock with Overweight rating  Investing.com Fri, 14 Nov 2025 08:54:32 GMT
 How Enanta Pharmaceuticals Inc. (ENTA) Affects Rotational Strategy Timing  news.stocktradersdaily.com Wed, 12 Nov 2025 21:10:02 GMT
 pfizer battles another paxlovid lawsuit from enanta  MSN Mon, 10 Nov 2025 06:02:52 GMT

Enanta Pharmaceuticals, Inc
(NASDAQ:ENTA) 

ENTA stock logo

Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, non-alcoholic steatohepatitis, SARS-CoV-2, human metapneumovi...

Founded: 1995
Full Time Employees: 141
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends